Dysregulated KDR and FLT1 Gene Expression in Colorectal Cancer Patients

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 234

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RBMB-8-3_005

تاریخ نمایه سازی: 22 دی 1399

Abstract:

Background: Colorectal cancer (CRC) is one of the most commonly-diagnosed malignancies throughout the world and the fourth-leading cause of cancer deaths globally. Angiogenesis and the resultant tumor neovascularization is a well-known cancer hallmark. Here we investigated the expression of FLT1 and KDR, the influential genes in angiogenesis regulation, in CRC patients. Methods: We assessed FLT1 and KDR mRNA expression in 47 CRC samples and matched adjacent non-cancerous tissues (ANCT) by quantitative real-time PCR. The Spearmen correlation coefficient and receiver operating characteristic (ROC) curves were also examined. Results: Both genes were expressed at significantly greater levels in CRC tissues than in ANCT (p < 0.05). A significant association was found between KDR expression and disease stage and lymph status in CRC patients. Furthermore, the Spearman correlation demonstrated a moderate correlation between FLT1 and KDR expression in CRC samples. Finally, ROC curve analysis demonstrated that FLT1 had the greatest sensitivity (85.1%), while the greatest specificity was achieved by a combination of the two genes. Conclusions: The dysregulated FLT1 and KDR expression, in addition to the observed correlation and ROC curve results, indicate the critical importance of angiogenesis among the cancer pathways in CRC. These data can broaden our current knowledge of angiogenesis in CRC to improve disease diagnosis and patient treatment.  

Authors

Fatemeh Mohammad Rezaei

Department of Medical Genetic, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. & Tuberculosis and Lung Disease Research Center of Tabriz University of Medical Sciences, Tabriz, Iran.

Shahryar Hashemzadeh

Tuberculosis and Lung Disease Research Center of Tabriz University of Medical Sciences, Tabriz, Iran. & General and Vascular Surgery Department of Tabriz University of Medical Sciences, Tabriz, Iran.

Reyhaneh Ravanbakhsh Gavgani

Department of biological science, school of natural science, University of Tabriz, Tabriz, Iran.

Mohammadali Hosseinpour Feizi

Department of Animal Biology, University of Tabriz, Tabriz, Iran.

Nasser Pouladi

Department of Biology, Azarbaijan Shahid Madani University, Tabriz, Iran.

Hossein Samadi Kafil

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Leila Rostamizadeh

Department of Medical Genetic, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Vahid Kholghi Oskooei

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammad Taheri

Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Ebrahim Sakhinia

Tabriz Genetic Analysis Center (TGAC), Tabriz University of Medical Sciences, Tabriz, Iran.